We recount a single-center experience with cardiac immunity-related adverse effects in patients treated with immune checkpoint inhibitors. Of 2,830 patients, 9 patients (0.3%) developed cardiac immunity-related adverse effects (4 cases of cardiomyopathies, 2 of myocarditis, 2 of acute pericarditis, and 1 of large pericardial effusion). Disease profiles, hospital courses, and outcomes are reported. ().
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298653 | PMC |
| http://dx.doi.org/10.1016/j.jaccas.2019.11.080 | DOI Listing |
Publication Analysis
Top Keywords
immune checkpoint
8
checkpoint inhibitors
8
cardiac immunity-related
8
immunity-related adverse
8
adverse effects
8
myocardial pericardial
4
pericardial toxicity
4
toxicity associated
4
associated immune
4
inhibitors cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!